Literature DB >> 6218796

Biocidal braided sutures.

G T Rodeheaver, L D Kurtz, W T Bellamy, S L Smith, H Farris, R F Edlich.   

Abstract

Once sutures become contaminated it is difficult for local tissue defenses or antibiotics to eliminate the bacteria and prevent infection. Impregnation of sutures with antibiotics before implantation is one way to prevent bacterial seeding of the suture surface. In this study, braided silk and Dacron sutures were impregnated with the antibiotic complex, neomycin palmitate. Using our standard wound model in the mouse, the efficacy of these biocidal sutures was determined in the presence of Staphylococcus aureus, Escherichia coli, Proteus mirabilis, and Pseudomonas aeruginosa. Implantation of these biocidal sutures into tissue contaminated with 10(7) organisms resulted in substantially decreased numbers of bacteria as compared with that of tissue receiving control sutures. In most cases, the tissue bacterial counts in the presence of biocidal sutures were also considerably lower than that for similarly contaminated tissue without a suture. Consequently, the presence of the neomycin palmitate eliminated the infection-potentiating effect of the suture. The therapeutic benefit of the biocidal sutures was related to the dose of antibiotic complex and was not adversely affected by delaying suture implantation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6218796     DOI: 10.1001/archsurg.1983.01390030054008

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Healthcare associated infection: novel strategies and antimicrobial implants to prevent surgical site infection.

Authors:  David Leaper; Andrew J McBain; Axel Kramer; Ojan Assadian; Jose Luis Alfonso Sanchez; Jukka Lumio; Martin Kiernan
Journal:  Ann R Coll Surg Engl       Date:  2010-09       Impact factor: 1.891

2.  Triclosan-coated sutures reduce wound infections after hepatobiliary surgery--a prospective non-randomized clinical pathway driven study.

Authors:  Christoph Justinger; Jochen Schuld; Jens Sperling; Otto Kollmar; Sven Richter; Martin Karl Schilling
Journal:  Langenbecks Arch Surg       Date:  2011-04-01       Impact factor: 3.445

3.  Prevention of abdominal wound infection (PROUD trial, DRKS00000390): study protocol for a randomized controlled trial.

Authors:  Ulrike Heger; Sabine Voss; Phillip Knebel; Colette Doerr-Harim; Jens Neudecker; Christoph Schuhmacher; Eugen Faist; Markus K Diener; Meinhard Kieser; Christoph M Seiler; Markus W Büchler
Journal:  Trials       Date:  2011-11-21       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.